Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

--
Data as of --
-- -- / --
Today’s Change
0.85
Today|||52-Week Range
2.20
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$47.1M

Company Description

AVEO Pharmaceuticals, Inc. is a cancer therapeutics company, which is discovering, developing and commercializing targeted therapies to treat patients with cancer. Its proprietary human response platform provides the company unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates. The company's product candidates include AV-203, ficlatuzumab, tivozanib and AV-380. AVEO Pharmaceuticals was founded by Ronald A. DePinho, Lynda Chin and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Contact Information

AVEO Pharmaceuticals, Inc.
650 East Kendall Street
Cambridge Massachusetts 02142
P:(617) 299-5000
Investor Relations:
(617) 299-5810

Employees

Shareholders

Mutual fund holders7.11%
Other institutional27.39%
Individual stakeholders13.23%

Top Executives

Tuan Ha-NgocPresident, Chief Executive Officer, CFO & Director
Jeno GyurisChief Scientific Officer & Senior Vice President
Joseph VittiglioSecretary, General Counsel & Senior Vice President
Michael P. BaileyChief Business Officer
Matthew D. DallasTreasurer, Chief Accounting Officer & VP-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.